Broadfin Capital, LLC Buys Adamas Pharmaceuticals Inc, La Jolla Pharmaceutical Co, AMAG Pharmaceuticals Inc, Sells Ignyta Inc, Endo International PLC, Mirati Therapeutics Inc

• New Purchases: ADMS, AMAG, KALA, GKOS, ANAB, CI, MRK, SLGL, ESPR, PCRX,
• Added Positions: LJPC, NUVA, GWPH, VCEL, ZGNX, AMRN, PRTK, TTPH, ATRS, AVDL,
• Reduced Positions: MRTX, ANGO, IOVA, RTRX, HRTX, HZNP, BABY, CDTX, CORI, SBBP,
• Sold Out: RXDX, ENDP, MDCO, IDRA, BAX, CGNT, RGLS, AGRX, NSTG, ATEC,

For the details of Broadfin Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Broadfin+Capital%2C+LLC

1. La Jolla Pharmaceutical Co (LJPC) - 1,656,720 shares, 7.76% of the total portfolio. Shares added by 60.87%
2. Mirati Therapeutics Inc (MRTX) - 1,443,948 shares, 6.97% of the total portfolio. Shares reduced by 41.01%
3. Heron Therapeutics Inc (HRTX) - 1,581,416 shares, 6.87% of the total portfolio. Shares reduced by 22.04%
4. Horizon Pharma PLC (HZNP) - 2,564,175 shares, 5.73% of the total portfolio. Shares reduced by 15.04%
5. Corium International Inc (CORI) - 3,119,645 shares, 5.63% of the total portfolio. Shares reduced by 9.11%

Broadfin Capital, LLC initiated holding in Adamas Pharmaceuticals Inc. The purchase prices were between $23.67 and $42.65, with an estimated average price of $31.53. The stock is now traded at around $31.83. The impact to a portfolio due to this purchase was 4.27%. The holding were 1,135,203 shares as of 2018-03-31.

Broadfin Capital, LLC initiated holding in AMAG Pharmaceuticals Inc. The purchase prices were between $12.3 and $21.15, with an estimated average price of $16.92. The stock is now traded at around $22.95. The impact to a portfolio due to this purchase was 1.9%. The holding were 598,800 shares as of 2018-03-31.

Broadfin Capital, LLC initiated holding in Kala Pharmaceuticals Inc. The purchase prices were between $12.26 and $18.98, with an estimated average price of $15.26. The stock is now traded at around $17.30. The impact to a portfolio due to this purchase was 1.7%. The holding were 681,239 shares as of 2018-03-31.

Broadfin Capital, LLC initiated holding in Glaukos Corp. The purchase prices were between $26.05 and $34.5, with an estimated average price of $30.28. The stock is now traded at around $32.73. The impact to a portfolio due to this purchase was 1.43%. The holding were 293,900 shares as of 2018-03-31.

Broadfin Capital, LLC initiated holding in AnaptysBio Inc. The purchase prices were between $100.5 and $128.55, with an estimated average price of $112.73. The stock is now traded at around $89.74. The impact to a portfolio due to this purchase was 1.3%. The holding were 79,200 shares as of 2018-03-31.

Broadfin Capital, LLC initiated holding in Merck & Co Inc. The purchase prices were between $53.41 and $62.07, with an estimated average price of $56.63. The stock is now traded at around $59.68. The impact to a portfolio due to this purchase was 1.12%. The holding were 130,900 shares as of 2018-03-31.

Broadfin Capital, LLC added to a holding in La Jolla Pharmaceutical Co by 60.87%. The purchase prices were between $28.17 and $39.24, with an estimated average price of $32.24. The stock is now traded at around $30.89. The impact to a portfolio due to this purchase was 2.94%. The holding were 1,656,720 shares as of 2018-03-31.

Broadfin Capital, LLC added to a holding in NuVasive Inc by 214.61%. The purchase prices were between $46.03 and $61.28, with an estimated average price of $50.71. The stock is now traded at around $49.37. The impact to a portfolio due to this purchase was 1.45%. The holding were 258,292 shares as of 2018-03-31.

Broadfin Capital, LLC added to a holding in GW Pharmaceuticals PLC by 42.38%. The purchase prices were between $110.14 and $139.71, with an estimated average price of $125.74. The stock is now traded at around $144.54. The impact to a portfolio due to this purchase was 0.92%. The holding were 175,030 shares as of 2018-03-31.

Broadfin Capital, LLC added to a holding in Vericel Corp by 661.22%. The purchase prices were between $5.7 and $12.3, with an estimated average price of $8.27. The stock is now traded at around $13.40. The impact to a portfolio due to this purchase was 0.89%. The holding were 658,900 shares as of 2018-03-31.

Broadfin Capital, LLC added to a holding in Amarin Corp PLC by 80.69%. The purchase prices were between $2.99 and $4.44, with an estimated average price of $3.71. The stock is now traded at around $3.21. The impact to a portfolio due to this purchase was 0.44%. The holding were 2,078,799 shares as of 2018-03-31.

Broadfin Capital, LLC sold out a holding in Ignyta Inc. The sale prices were between $26.75 and $27, with an estimated average price of $26.93.

Broadfin Capital, LLC sold out a holding in Endo International PLC. The sale prices were between $5.79 and $8.86, with an estimated average price of $6.99.

Broadfin Capital, LLC sold out a holding in The Medicines Co. The sale prices were between $24.83 and $35.48, with an estimated average price of $31.25.

Broadfin Capital, LLC sold out a holding in Idera Pharmaceuticals Inc. The sale prices were between $1.77 and $2.55, with an estimated average price of $2.02.

Broadfin Capital, LLC sold out a holding in Baxter International Inc. The sale prices were between $62.56 and $72.26, with an estimated average price of $67.6.

Broadfin Capital, LLC sold out a holding in Cogentix Medical Inc. The sale prices were between $2.71 and $3.87, with an estimated average price of $3.13.